Finkel, SI, Costa e Silva, J, Cohen, G, Miller, S, Sartorius, N.
Behavioral and psychological signs and symptoms of dementia:
a consensus statement on current knowledge and implications for research
and treatment. Int Psychogeriatr
Parnetti, L, Amici, S, Lanari, A, Gallai, V.
Pharmacological treatment of non–cognitive disturbances in
dementia disorders. Mech Ageing Dev
2001; 122: 2063–9.
Testad, I, Auer, S, Mittelman, M, Ballard, C, Fossey, J, Donabauer, Y,
Nursing home structure and association with agitation and use
of psychotropic drugs in nursing home residents in three countries:
Norway, Austria and England. Int J Geriatr
2010; 25: 725–31.
Coehlo, DP, Hooker, K, Bowman, S.
Institutional placement of persons with dementia: what
predicts occurrence and timing?
J Fam Nurs
2007; 13: 253–77.
Burns, A, Iliffe, S.
The Use of Antipsychotic Medication for People With Dementia: Time
for Action. Department of
Kales, HC, Kim, HM, Zivin, K, Valenstein, M, Seyfried, LS, Chiang, C,
Risk of mortality among individual antipsychotics in patients
with dementia. Am J Psychiatry
2012; 169: 71–9.
Schneider, LS, Dagerman, KS, Insel, P.
Risk of death with atypical antipsychotic drug treatment for
dementia: meta–analysis of randomized placebo–controlled
2005; 294: 1934–43.
Prince, MJ, Costa, E.
A Systematic Review of the Evidence on the Efficacy and Harm
Associated with the Use of Conventional and Atypical Antipsychotics for
the Treatment of Behavioural Disturbance and Psychosis in
Dementia. Department of Health,
Alanen, HM, Finne–Soveri, H, Noro, A, Leinonen, E.
Use of antipsychotics in older home care patients in
Finland. Drugs Aging
2008; 25: 335–42.
McGrath, AM, Jackson, GA.
Survey of neuroleptic prescribing in residents of nursing
homes in Glasgow. BMJ
1996; 312: 611–2.
Alldred, DP, Petty, DR, Bowie, P, Zermansky, AG, Raynor, DK.
Antipsychotic prescribing patterns in care homes and
relationship with dementia. Psychiatr
2007; 31: 329–32.
Monette, J, Alessa, W, McCusker, J, Cole, M, Voyer, P, Champoux, N,
Association of resident and room characteristics with
antipsychotic use in long–term care facilities (LTCF).
Arch Gerontol Geriatr
2012; 55: 66–9.
Chen, Y, Briesacher, BA, Field, TS, Tjia, J, Lau, DT, Gurwitz, JH.
Unexplained variation across US nursing homes in
antipsychotic prescribing rates. Arch Intern
Weintraub, D, Chen, P, Ignacio, RV, Mamikonyan, E, Kales, HC.
Patterns and trends in antipsychotic prescribing for
Parkinson disease psychosis. Arch Neurol
Tariot, PN, Schneider, L, Katz, IR, Mintzer, JE, Street, J, Copenhaver, M,
Quetiapine treatment of psychosis associated with dementia: a
double–blind, randomized, placebo–controlled clinical
trial. Am J Geriatr Psychiatry
2006; 14: 767–76.
Sultzer, DL, Davis, SM, Tariot, PN, Dagerman, KS, Lebowitz, BD, Lyketsos, CG, . Clinical symptom responses
to atypical antipsychotic medications in Alzheimer's disease: phase 1
outcomes from the CATIE–AD effectiveness trial.
Am J Psychiatry
2008; 165: 844–54.
Dorsey, ER, Rabbani, A, Gallagher, SA, Conti, RM, Alexander, GC.
Impact of FDA black box advisory on antipsychotic medication
use. Arch Intern Med
Ballard, C, Hanney, ML, Theodoulou, M, Douglas, S, McShane, R, Kossakowski, K,
The dementia antipsychotic withdrawal trial (DART–AD):
long–term follow-up of a randomised placebo-controlled
trial. Lancet Neurol
2009; 8: 151–7.
Soyinka, A, Lawley, D.
Antipsychotic prescribing for behavioural and psychological
symptoms of dementia. Psychiatr Bull
2007; 31: 176–8.
Malone, D, Bradley, P, Lindesay, J.
Olanzapine and risperidone prescriptions for people with
dementia in care. Psychiatr Bull
2007; 31: 459–62.
Husebo, BS, Ballard, C, Sandvik, R, Nilsen, OB, Aarsland, D.
Efficacy of treating pain to reduce behavioural disturbances
in residents of nursing homes with dementia: cluster randomised clinical
Seitz, DP, Adunuri, N, Gill, SS, Gruneir, A, Herrmann, N, Rochon, P.
Antidepressants for agitation and psychosis in
dementia. Cochrane Database Syst Rev
Banerjee, S, Hellier, J, Dewey, M, Romeo, R, Ballard, C, Baldwin, R,
Sertraline or mirtazapine for depression in dementia
(HTA–SADD): a randomised, multicentre, double–blind, placebo-controlled
2011; 378: 403–11.
Lonergan, E, Luxenberg, J.
Valproate preparations for agitation in
dementia. Cochrane Database Syst Rev
Fox, C, Richardson, K, Maidment, ID, Savva, GM, Matthews, FE, Smithard, D,
Anticholinergic medication use and cognitive impairment in
the older population: the medical research council cognitive function and
ageing study. J Am Geriatr Soc
2011; 59: 1477–83.
Langballe, EM, Engdahl, B, Seabaek, G, Nordeng, H.
Concomitant use of antidementia drugs with psychotropic drugs
in Norway – a population–based study.
Pharmacoepidemiol Drug Saf
2011; 20: 1319–26.
Antipsychotic prescribing in nursing homes: an audit
report. Qual Primary Care
2009; 17: 359–62.
Schembri Wismayer, F, Sipos, A.
Neuroleptics in dementia: two consecutive surveys of
prescribing practice at the interface of hospital and primary
care. Psychiatr Bull
1999; 23: 409–12.
Stuijt, CC, Franssen, EJ, Egberts, AC, Hudson, SA.
Appropriateness of prescribing among elderly patients in a
Dutch residential home: observational study of outcomes after a
pharmacist–led medication review. Drugs
2008; 25: 947–54.